Authors: Urtishak, K McCafferty, G Zaratin, P Scheideler, M Grugni, M Artico, M Hieble, JP

Citation: K. Urtishak et al., Activity of N-(phenethyl)phenylethanolamines at beta(1) and beta(2) adrenoceptors: Structural modifications can result in selectivity for either subtype, PHARMACOL, 62(2), 2001, pp. 113-118

Authors: Blaney, FE Raveglia, LF Artico, M Cavagnera, S Dartois, C Farina, C Grugni, M Gagliardi, S Luttmann, MA Martinelli, M Nadler, GMMG Parini, C Petrillo, P Sarau, HM Scheideler, MA Hay, DWP Giardina, GAM

Citation: Fe. Blaney et al., Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists, J MED CHEM, 44(11), 2001, pp. 1675-1689

Authors: Giardina, GA Grugni, M Raveglia, LF

Citation: Ga. Giardina et al., Recent advances in neurokinin-3 receptor antagonists, EXPERT OP T, 10(6), 2000, pp. 939-960

Authors: Giardina, GAM Raveglia, LF Grugni, M Sarau, HM Farina, C Medhurst, AD Graziani, D Schmidt, DB Rigolio, R Luttmann, M Cavagnera, S Foley, JJ Vecchietti, V Hay, DWP

Citation: Gam. Giardina et al., Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412), J MED CHEM, 42(6), 1999, pp. 1053-1065

Authors: Giardina, GAM Artico, M Cavagnera, S Cerri, A Consolandi, E Gagliardi, S Graziani, D Grugni, M Hay, DWP Luttmann, MA Mena, R Raveglia, LF Rigolio, R Sarau, HM Schmidt, DB Zanoni, G Farina, C

Citation: Gam. Giardina et al., Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists, FARMACO, 54(6), 1999, pp. 364-374